BEECHES MEDICAL PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: M82018 | SHREWSBURY, SY3 0PF
Showing results 401-450 of 582
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 29 | 32 | £3.7K | -18.8% ▼ | |
| Ethosuximide | 28 | 9,600 | £8.0K | +89.8% ▲ |
| Quinine bisulfate | 28 | 820 | £148 | -27.9% ▼ |
| Mefenamic acid | 28 | 1,230 | £243 | -38.0% ▼ |
| Febuxostat | 28 | 868 | £68 | -25.0% ▼ |
| Betamethasone esters | 28 | 4,010 | £420 | -53.6% ▼ |
| 28 | 220 | £836 | +32.4% ▲ | |
| Bempedoic acid | 27 | 756 | £1.4K | -17.6% ▼ |
| Clonidine hydrochloride | 27 | 2,828 | £300 | -49.4% ▼ |
| Testosterone undecanoate | 27 | 27 | £2.4K | +6.3% ▲ |
| Alfuzosin hydrochloride | 27 | 1,320 | £220 | -62.3% ▼ |
| Ferrous gluconate | 27 | 1,344 | £38 | -43.5% ▼ |
| Leflunomide | 27 | 810 | £56 | -28.7% ▼ |
| 27 | 305 | £129 | -31.5% ▼ | |
| 27 | 2,402 | £169 | -1.8% vs avg | |
| Sennosides | 26 | 5,700 | £121 | -15.8% ▼ |
| Ivabradine | 26 | 1,120 | £135 | -72.6% ▼ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 26 | 310.8K | £4.4K | -40.6% ▼ |
| 26 | 3,950 | £192 | -52.1% ▼ | |
| Budesonide | 25 | 2,324 | £1.9K | +59.6% ▲ |
| Lisinopril with diuretic | 25 | 728 | £261 | +21.9% ▲ |
| Amisulpride | 25 | 1,500 | £405 | -64.4% ▼ |
| Aspirin | 25 | 350 | £11 | +154.4% ▲ |
| Nefopam hydrochloride | 25 | 849 | £39 | -77.9% ▼ |
| Alprostadil | 25 | 127 | £1.3K | +46.2% ▲ |
| Alfacalcidol | 25 | 900 | £180 | -79.8% ▼ |
| Other multivitamin preparations | 25 | 1,075 | £255 | -85.5% ▼ |
| Bempedoic acid/Ezetimibe | 24 | 672 | £1.2K | -60.7% ▼ |
| Betamethasone sodium phosphate | 24 | 250 | £53 | -7.4% ▼ |
| 24 | 427 | £216 | +75.6% ▲ | |
| 24 | 300 | £1.4K | +543.2% ▲ | |
| 24 | 990 | £3.6K | +31.6% ▲ | |
| Naratriptan hydrochloride | 23 | 348 | £69 | -12.0% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 23 | 24.1K | £371 | +0.4% vs avg |
| Sodium chloride | 23 | 1,576 | £885 | -22.7% ▼ |
| 23 | 170 | £185 | -26.1% ▼ | |
| Zolpidem tartrate | 22 | 336 | £16 | -75.6% ▼ |
| Rasagiline mesilate | 22 | 784 | £449 | -40.8% ▼ |
| Fezolinetant | 22 | 616 | £909 | +355.4% ▲ |
| Sodium fluoride | 22 | 1,752 | £182 | -33.7% ▼ |
| Dexpanthenol | 22 | 2,200 | £129 | +320.6% ▲ |
| 22 | 15.0K | £211 | -75.9% ▼ | |
| 22 | 143 | £400 | -9.0% ▼ | |
| Zinc oxide | 21 | 567 | £81 | +1.5% vs avg |
| Ciclesonide | 21 | 21 | £655 | +42.6% ▲ |
| Opicapone | 21 | 630 | £1.2K | +9.7% ▲ |
| Etonogestrel | 21 | 21 | £1.7K | -27.3% ▼ |
| Tube feed 2 kcal/ml with fibre (0914011) | 21 | 522.0K | £12.2K | +98.0% ▲ |
| Other barrier preparations | 21 | 720 | £76 | +254.9% ▲ |
| Heparinoid | 21 | 1,050 | £79 | +61.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.